Zurlo, M.;                     Romagnoli, R.;                     Oliva, P.;                     Gasparello, J.;                     Finotti, A.;                     Gambari, R.    
        Synergistic Effects of A Combined Treatment of Glioblastoma U251 Cells with An Anti-miR-10b-5p Molecule and An AntiCancer Agent Based on 1-(3′,4′,5′-Trimethoxyphenyl)-2-Aryl-1H-Imidazole Scaffold. Int. J. Mol. Sci. 2022, 23, 5991.
    https://doi.org/10.3390/ijms23115991
    AMA Style
    
                                Zurlo M,                                 Romagnoli R,                                 Oliva P,                                 Gasparello J,                                 Finotti A,                                 Gambari R.        
                Synergistic Effects of A Combined Treatment of Glioblastoma U251 Cells with An Anti-miR-10b-5p Molecule and An AntiCancer Agent Based on 1-(3′,4′,5′-Trimethoxyphenyl)-2-Aryl-1H-Imidazole Scaffold. International Journal of Molecular Sciences. 2022; 23(11):5991.
        https://doi.org/10.3390/ijms23115991
    
    Chicago/Turabian Style
    
                                Zurlo, Matteo,                                 Romeo Romagnoli,                                 Paola Oliva,                                 Jessica Gasparello,                                 Alessia Finotti,                                 and Roberto Gambari.        
                2022. "Synergistic Effects of A Combined Treatment of Glioblastoma U251 Cells with An Anti-miR-10b-5p Molecule and An AntiCancer Agent Based on 1-(3′,4′,5′-Trimethoxyphenyl)-2-Aryl-1H-Imidazole Scaffold" International Journal of Molecular Sciences 23, no. 11: 5991.
        https://doi.org/10.3390/ijms23115991
    
    APA Style
    
                                Zurlo, M.,                                 Romagnoli, R.,                                 Oliva, P.,                                 Gasparello, J.,                                 Finotti, A.,                                 & Gambari, R.        
        
        (2022). Synergistic Effects of A Combined Treatment of Glioblastoma U251 Cells with An Anti-miR-10b-5p Molecule and An AntiCancer Agent Based on 1-(3′,4′,5′-Trimethoxyphenyl)-2-Aryl-1H-Imidazole Scaffold. International Journal of Molecular Sciences, 23(11), 5991.
        https://doi.org/10.3390/ijms23115991